Afuco™ Anti-S. epidermidis LTA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H53) (CAT#: AFC-TAB-H53)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. It is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Specifications
- Host Species
- Chimeric
- Derivation
- Chimeric (mouse/human)
- Type
- ADCC enhanced antibody
- Specificity
- Staphylococcus epidermidis lipoteichoic acid [Staphylococcus epidermidis]
- Species Reactivity
- S. epidermidis
- Applications
- FuncS, IF, Neut, ELISA, FC, IP
- Conjugate
- Unconjugated
- Generic Name
- Pagibaximab
- Related Disease
- Staphylococcal sepsis in infants with low birth weight
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- Lipoteichoic acid; LTA; S. epidermidis LTA; Staphylococcus epidermidis lipoteichoic acid
Related Resources
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "pagibaximab"
Anti-S. Epidermidis LTA Recombinant Antibody (Pagibaximab)Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
DrugMonitor™ Anti-Pagibaximab Antibody (VS-1224-YC880)Pagibaximab is a chimeric monoclonal antibody developed to prevent staphylococcal sepsis in low-birth-weight infants. The DrugMonitor™ Anti-Pagibaximab Antibody (VS-1224-YC880) is an anti-drug antibody (ADA) against Pagibaximab. This drug-based antibody is raised in mice immunized with the Pagibaximab. The anti-Pagibaximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Pagibaximab in samples.
See other products for "S. epidermidis LTA"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H53 | Anti-S. Epidermidis LTA Recombinant Antibody (Pagibaximab) | ELISA | IgG1 - kappa |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-H53. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: Neut, Inhib, FC, ELISA
Application: FC, IB, Block, Inhib, FuncS, ELISA, FACS, IP, IF
Application: WB, ELISA, FC, IHC, IP
Application: WB, ELISA, IF, FuncS, Apop, BA
Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR
Application: ELISA, FuncS, Neut, IF, WB, EM, Inhib, IHC
Application: ELISA, FC, Inhib, IHC-Fr, WB, IP
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.